Skip to main content

Advertisement

Log in

Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Previous retrospective studies have shown that laparoscopic spleen-preserving D2 total gastrectomy (LSTG) for advanced upper third gastric cancer (AUTGC) is safe. However, all previous studies were underpowered. We therefore conducted a prospective, multicenter study to evaluate the technical safety and feasibility of LSTG for patients with AUTGC.

Methods

Patients diagnosed with AUTGC (cT2-4a, N−/+, M0) underwent LSTG at 19 institutions between September 2016 and October 2017 were included. The number of No. 10 lymph node (LN) dissections, metastasis rates, intraoperative and postoperative complications were investigated.

Results

A total of 251 patients were enrolled in the study, and 242 patients were eligible for the per protocol analysis. The average numbers of No. 10 LN dissections and metastases were 2.4 and 0.1, respectively. Eighteen patients (7.4%) had No. 10 LN metastases, and among patients with advanced gastric cancer, the rate of No. 10 LN metastasis was 8.1% (18/223). pN3 status was an independent risk factor for No. 10 LN metastasis. Intraoperative complications occurred in 7 patients, but no patients required conversion to open surgery or splenectomy. The overall postoperative complication rate was 13.6% (33/242). The major complication and mortality rates were 3.3% (8/242) and 0.4% (1/242), respectively. The number of retrieved No. 10 LNs, No. 10 LN metastasis and TNM stage had no significant influence on postoperative complication rates.

Conclusion

LSTG for AUTGC was safe and effective when performed by very experienced surgeons, this technique could be used in patients who needed splenic hilar lymph node dissection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 2:87–108

    Google Scholar 

  2. Falk J, Carstens H, Lundell L, Albertsson M (2007) Incidence of carcinoma of the oesophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol 8:1070–1074

    Google Scholar 

  3. Blot WJ, Devesa SS, Kneller RW, Fraumeni JJ (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 10:1287–1289

    Google Scholar 

  4. Ahn HS, Lee HJ, Yoo MW et al (2011) Changes in clinicopathological features and survival after gastrectomy for gastric cancer over a 20-year period. Br J Surg 2:255–260

    Google Scholar 

  5. Huang CM, Chen T, Lin JX et al (2017) The effects of laparoscopic spleen-preserving splenic hilar lymphadenectomy on the surgical outcome of proximal gastric cancer: a propensity score-matched, case-control study. Surg Endosc 3:1383–1392

    Google Scholar 

  6. Yang K, Chen XZ, Hu JK, Zhang B, Chen ZX, Chen JP (2009) Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis. World J Gastroenterol 42:5352–5359

    Google Scholar 

  7. Yu W, Choi GS, Chung HY (2006) Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 5:559–563

    Google Scholar 

  8. Sano T, Sasako M, Mizusawa J et al (2017) Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Ann Surg 2:277–283

    Google Scholar 

  9. Brar SS, Seevaratnam R, Cardoso R, Law C, Helyer L, Coburn N (2012) A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer. Gastric Cancer 15(1):89–99

    Google Scholar 

  10. Zhang CH, Zhan WH, He YL, Chen CQ, Huang MJ, Cai SR (2007) Spleen preservation in radical surgery for gastric cardia cancer. Ann Surg Oncol 4:1312–1319

    Google Scholar 

  11. Kawamura Y, Satoh S, Suda K, Ishida Y, Kanaya S, Uyama I (2015) Critical factors that influence the early outcome of laparoscopic total gastrectomy. Gastric Cancer 3:662–668

    Google Scholar 

  12. Hyung WJ, Lim JS, Song J, Choi SH, Noh SH (2008) Laparoscopic spleen-preserving splenic hilar lymph node dissection during total gastrectomy for gastric cancer. J Am Coll Surg 2:e6–e11

    Google Scholar 

  13. Lu J, Huang CM, Zheng CH et al (2016) Major perioperative complications in laparoscopic spleen-preserving total gastrectomy for gastric cancer: perspectives from a high-volume center. Surg Endosc 3:1034–1042

    Google Scholar 

  14. Sakuramoto S, Kikuchi S, Futawatari N et al (2009) Laparoscopy-assisted pancreas- and spleen-preserving total gastrectomy for gastric cancer as compared with open total gastrectomy. Surg Endosc 11:2416–2423

    Google Scholar 

  15. Guo X, Peng Z, Lv X et al (2018) Randomized controlled trial comparing short-term outcomes of laparoscopic and open splee-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: an interim report. J Surg Oncol 8:1264–1270

    Google Scholar 

  16. Hur H, Jeon HM, Kim W (2008) Laparoscopic pancreas- and spleen-preserving D2 lymph node dissection in advanced (cT2) upper-third gastric cancer. J Surg Oncol 2:169–172

    Google Scholar 

  17. Son T, Lee JH, Kim YM, Kim HI, Noh SH, Hyung WJ (2014) Robotic spleen-preserving total gastrectomy for gastric cancer: comparison with conventional laparoscopic procedure. Surg Endosc 9:2606–2615

    Google Scholar 

  18. Sakuramoto S, Sasako M, Yamaguchi T et al (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 18:1810–1820

    Google Scholar 

  19. Hu Y, Huang C, Sun Y et al (2016) Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol 12:1350–1357

    Google Scholar 

  20. Japanese Classification of Gastric Carcinoma (2011) Japanese Classification of Gastric Carcinoma: 3rd english edition. Gastric Cancer 2:101–112

    Google Scholar 

  21. Mizuno A, Kanda M, Kobayashi D et al (2016) Adverse effects of intraoperative blood loss on long-term outcomes after curative gastrectomy of patients with stage II/III gastric cancer. Dig Surg 2:121–128

    Google Scholar 

  22. Kim W, Kim HH, Han SU et al (2016) Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg 1:28–35

    Google Scholar 

  23. Wente MN, Veit JA, Bassi C et al (2007) Postpancreatectomy hemorrhage (PPH): an international study group of pancreatic surgery (ISGPS) definition. Surgery 1:20–25

    Google Scholar 

  24. Jung MR, Park YK, Seon JW, Kim KY, Cheong O, Ryu SY (2012) Definition and classification of complications of gastrectomy for gastric cancer based on the accordion severity grading system. World J Surg 10:2400–2411

    Google Scholar 

  25. Orsenigo E, Bissolati M, Socci C et al (2014) Duodenal stump fistula after gastric surgery for malignancies: a retrospective analysis of risk factors in a single centre experience. Gastric Cancer 4:733–744

    Google Scholar 

  26. Bassi C, Dervenis C, Butturini G et al (2005) Postoperative pancreatic fistula: an International Study Group (ISGPF) definition. Surgery 1:8–13

    Google Scholar 

  27. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 10:606–608

    Google Scholar 

  28. Assumpcao L, Cameron JL, Wolfgang CL et al (2008) Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience. J Gastrointest Surg 11:1915–1923

    Google Scholar 

  29. Holte K, Kehlet H (2000) Postoperative ileus: a preventable event. Br J Surg 11:1480–1493

    Google Scholar 

  30. Arozullah AM, Khuri SF, Henderson WG, Daley J (2001) Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 10:847–857

    Google Scholar 

  31. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2:205–213

    Google Scholar 

  32. Lee JH, Park DJ, Kim HH, Lee HJ, Yang HK (2012) Comparison of complications after laparoscopy-assisted distal gastrectomy and open distal gastrectomy for gastric cancer using the Clavien-Dindo classification. Surg Endosc 5:1287–1295

    Google Scholar 

  33. Kubota T, Hiki N, Sano T et al (2014) Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol 3:891–898

    Google Scholar 

  34. Zheng CH, Xu M, Huang CM et al (2015) Anatomy and influence of the splenic artery in laparoscopic spleen-preserving splenic lymphadenectomy. World J Gastroenterol 27:8389–8397

    Google Scholar 

  35. Wang J, Huang C, Lu H, Zheng C (2009) Efficacy of combined splenectomy in proximal gastric cancer with no 10 lymph node metastasis. Chin J Gastrointest Surg 12(2):121–125

    Google Scholar 

  36. Watanabe M, Kinoshita T, Enomoto N, Shibasaki H, Nishida T (2016) Clinical significance of splenic hilar dissection with splenectomy in advanced proximal gastric cancer: an analysis at a single institution in Japan. World J Surg 5:1165–1171

    Google Scholar 

  37. Kosuga T, Ichikawa D, Okamoto K et al (2011) Survival benefits from splenic hilar lymph node dissection by splenectomy in gastric cancer patients: relative comparison of the benefits in subgroups of patients. Gastric Cancer 2:172–177

    Google Scholar 

  38. Huang CM, Zhang JR, Zheng CH et al (2014) A 346 case analysis for laparoscopic spleen-preserving no. 10 lymph node dissection for proximal gastric cancer: a single center study. PLoS ONE 9:e108480

    PubMed  PubMed Central  Google Scholar 

  39. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), Gastric Cancer. Version 2.2019—Jun 3, 2019

  40. Shin SH, Jung H, Choi SH et al (2009) Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer. Ann Surg Oncol 5:1304–1309

    Google Scholar 

  41. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F (2002) A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 4:401–407

    Google Scholar 

  42. Yang K, Lu ZH, Zhang WH et al (2015) Comparisons between different procedures of no. 10 lymphadenectomy for gastric cancer patients with total gastrectomy. Medicine. 33:e1305

    Google Scholar 

  43. Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 7:825–827

    Google Scholar 

Download references

Acknowledgements

The study was sponsored by the Scientific and technological innovation joint capital projects of Fujian Province (2016Y9031, 2017Y9011); Construction Project of Fujian Province Minimally Invasive Medical Center (No. [2017]171); The second batch of special support funds for Fujian Province innovation and entrepreneurship talents (2016B013); Chinese physicians association young physician respiratory research fund of Fujian province medical innovation project (2015-CXB-16).

Funding

The study was sponsored by the Scientific and technological innovation joint capital projects of Fujian Province (2016Y9031, 2017Y9011); Construction Project of Fujian Province Minimally Invasive Medical Center (No.[2017]171); The second batch of special support funds for Fujian Province innovation and entrepreneurship talents (2016B013); Chinese physicians association young physician respiratory research fund of Fujian province medical innovation project (2015-CXB-16).

Author information

Authors and Affiliations

Authors

Consortia

Contributions

CMH, CHZ, and PL designed the study. JL, PL, CHZ, and CMH wrote the first draft of the manuscript. YCX, GZ, LSC, GXL, ZKX, SY, ZGW, FQX, YHS, DPX, WBZ, JW, PWY, JKH, XQS, JFJ, ZYL, JY, YL, and LF critically evaluated, improved the study design and manuscript, and shared the responsibility for the final manuscript and the decision to submit. All of the authors were responsible for data collection and evaluation and approval of the manuscript.

Corresponding author

Correspondence to Chang-Ming Huang.

Ethics declarations

Disclosures

Drs. Chang-Ming Huang, Chao-Hui Zheng, Ping-Li, Jun-Lu, Yan-Chang Xu, Gang Zhao, Li-Sheng Cai, Guo-Xin Li, Ze-Kuan Xu, Su Yan, Zu-Guang Wu, Fang-Qin Xue, Yi-Hong Sun, Dong-Bo Xu, Wen-Bin Zhang, Jin-Wan, Pei-Wu Yu, Jian-Kun Hu, Xiang-Qian Su, Jia-Fu Ji, Zi-Yu Li, Jun You, Yong Li, and Lin-Fan have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 24305 kb)

Supplementary material 2 Supplementary Fig. 1 Schematic diagram of the No. 10 lymph node after cleaning (TIFF 13481 kb)

Supplementary material 3 Supplementary Fig. 2 Number of total and No. 10 LNs dissected at each center (TIFF 2931 kb)

464_2019_7306_MOESM4_ESM.tiff

Supplementary material 4 Supplementary Fig. 3 Comparison with other studies about spleen-preserving total gastrectomy (TIFF 745 kb)

464_2019_7306_MOESM5_ESM.tif

Supplementary material 5 Supplementary Fig. 4 Using Chi square test to compare with other studies about spleen-preserving total gastrectomy (TIFF 1076 kb)

Supplementary material 6 (DOCX 17 kb)

Supplementary material 7 (DOCX 13 kb)

Supplementary material 8 (DOCX 18 kb)

Supplementary material 9 (DOCX 20 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, CH., Xu, YC., Zhao, G. et al. Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial. Surg Endosc 34, 5062–5073 (2020). https://doi.org/10.1007/s00464-019-07306-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-019-07306-8

Keywords

Navigation